GETTING MY API IN PHARMACEUTICAL MANUFACTURING TO WORK

“The present predicament has exposed some structural weaknesses while in the EU’s medicines offer chain plus a substantial dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She advised that provide chain issues be tackled in an EU pharmaceutical system predicted to be introduced by the top in the 12 months.